Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 13 studies | 65% ± 18% | |
glutamatergic neuron | 11 studies | 57% ± 28% | |
GABAergic neuron | 8 studies | 50% ± 24% | |
neuron | 4 studies | 27% ± 12% | |
glycinergic amacrine cell | 3 studies | 36% ± 8% | |
astrocyte | 3 studies | 42% ± 28% | |
interneuron | 3 studies | 61% ± 26% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 36% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 95% | 701.24 | 2513 / 2642 | 43% | 2.97 | 304 / 705 |
thymus | 12% | 9.28 | 78 / 653 | 52% | 2.04 | 314 / 605 |
pancreas | 31% | 28.68 | 103 / 328 | 28% | 1.60 | 49 / 178 |
adrenal gland | 2% | 2.79 | 6 / 258 | 44% | 6.12 | 101 / 230 |
prostate | 28% | 42.22 | 69 / 245 | 15% | 0.31 | 74 / 502 |
peripheral blood | 42% | 56.62 | 394 / 929 | 0% | 0 | 0 / 0 |
lung | 14% | 11.22 | 79 / 578 | 10% | 0.53 | 121 / 1155 |
kidney | 4% | 4.13 | 4 / 89 | 12% | 0.28 | 111 / 901 |
intestine | 13% | 11.37 | 127 / 966 | 2% | 0.06 | 12 / 527 |
skin | 3% | 2.30 | 46 / 1809 | 12% | 1.01 | 58 / 472 |
eye | 0% | 0 | 0 / 0 | 10% | 0.68 | 8 / 80 |
liver | 7% | 4.84 | 16 / 226 | 2% | 0.03 | 8 / 406 |
stomach | 8% | 6.24 | 28 / 359 | 1% | 0.01 | 2 / 286 |
spleen | 8% | 6.50 | 20 / 241 | 0% | 0 | 0 / 0 |
bladder | 5% | 4.71 | 1 / 21 | 1% | 0.04 | 6 / 504 |
ovary | 2% | 2.53 | 4 / 180 | 1% | 0.02 | 4 / 430 |
esophagus | 0% | 0.35 | 5 / 1445 | 1% | 0.02 | 2 / 183 |
uterus | 0% | 0 | 0 / 170 | 1% | 0.07 | 6 / 459 |
adipose | 0% | 0.05 | 1 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.06 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
breast | 0% | 0 | 0 / 459 | 0% | 0 | 0 / 1118 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | TMEM132D |
Protein name | Transmembrane protein 132D (Mature oligodendrocytes transmembrane protein) (Mature OL transmembrane protein) |
Synonyms | MOLT HBE120 KIAA1944 |
Description | FUNCTION: Regulate neuronals morphology via inhibition of the WAVE regulatory complex (WCR), a complex that controls F-actin cytoskeletal dynamics. . |
Accessions | Q14C87 ENST00000389441.8 [Q14C87-2] ENST00000422113.7 [Q14C87-1] |